1. Home
  2. POWL vs APLS Comparison

POWL vs APLS Comparison

Compare POWL & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POWL
  • APLS
  • Stock Information
  • Founded
  • POWL 1947
  • APLS 2009
  • Country
  • POWL United States
  • APLS United States
  • Employees
  • POWL N/A
  • APLS N/A
  • Industry
  • POWL Electrical Products
  • APLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • POWL Energy
  • APLS Health Care
  • Exchange
  • POWL Nasdaq
  • APLS Nasdaq
  • Market Cap
  • POWL 3.3B
  • APLS 3.5B
  • IPO Year
  • POWL N/A
  • APLS 2017
  • Fundamental
  • Price
  • POWL $298.80
  • APLS $23.89
  • Analyst Decision
  • POWL Strong Buy
  • APLS Buy
  • Analyst Count
  • POWL 1
  • APLS 20
  • Target Price
  • POWL $312.00
  • APLS $34.11
  • AVG Volume (30 Days)
  • POWL 223.0K
  • APLS 2.0M
  • Earning Date
  • POWL 08-05-2025
  • APLS 11-04-2025
  • Dividend Yield
  • POWL 0.37%
  • APLS N/A
  • EPS Growth
  • POWL 34.62
  • APLS N/A
  • EPS
  • POWL 14.40
  • APLS N/A
  • Revenue
  • POWL $1,081,398,000.00
  • APLS $754,649,000.00
  • Revenue This Year
  • POWL $11.13
  • APLS $20.59
  • Revenue Next Year
  • POWL $5.51
  • APLS N/A
  • P/E Ratio
  • POWL $19.98
  • APLS N/A
  • Revenue Growth
  • POWL 14.32
  • APLS 20.02
  • 52 Week Low
  • POWL $146.02
  • APLS $16.10
  • 52 Week High
  • POWL $364.98
  • APLS $38.69
  • Technical
  • Relative Strength Index (RSI)
  • POWL 68.23
  • APLS 38.34
  • Support Level
  • POWL $251.55
  • APLS $27.26
  • Resistance Level
  • POWL $296.22
  • APLS $28.97
  • Average True Range (ATR)
  • POWL 11.93
  • APLS 1.00
  • MACD
  • POWL 1.55
  • APLS -0.68
  • Stochastic Oscillator
  • POWL 96.87
  • APLS 1.59

About POWL Powell Industries Inc.

Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: